These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 8139085)

  • 21. Impact of markedly elevated serum lipoprotein(a) levels (> or = 100 mg/dL) on the risk of coronary heart disease.
    Murase T; Okubo M; Amemiya-Kudo M; Hiraga T; Oka J; Shimada M; Igarashi T
    Metabolism; 2007 Sep; 56(9):1187-91. PubMed ID: 17697860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study.
    Parra HJ; Arveiler D; Evans AE; Cambou JP; Amouyel P; Bingham A; McMaster D; Schaffer P; Douste-Blazy P; Luc G
    Arterioscler Thromb; 1992 Jun; 12(6):701-7. PubMed ID: 1534257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial.
    Robins SJ; Collins D; Wittes JT; Papademetriou V; Deedwania PC; Schaefer EJ; McNamara JR; Kashyap ML; Hershman JM; Wexler LF; Rubins HB;
    JAMA; 2001 Mar; 285(12):1585-91. PubMed ID: 11268266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lipid risk factors of coronary heart disease during longterm observation of a Warsaw Pol-Monica population-based cohort].
    Chotkowska E; Jasiński B; Kupść W; Broda G
    Pol Arch Med Wewn; 1997 Jan; 97(1):37-46. PubMed ID: 9235550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma lipoprotein Lp(a), markers of haemostasis and inflammation, and risk and severity of coronary heart disease.
    Imhof A; Rothenbacher D; Khuseyinova N; Hoffmeister A; Maerz W; Nauck M; Scharnagl H; Koenig W; Brenner H
    Eur J Cardiovasc Prev Rehabil; 2003 Oct; 10(5):362-70. PubMed ID: 14663298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
    Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
    Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoprotein(a) interactions with lipid and nonlipid risk factors in early familial coronary artery disease.
    Hopkins PN; Wu LL; Hunt SC; James BC; Vincent GM; Williams RR
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2783-92. PubMed ID: 9409256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholestyramine therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. A short-term, double-blind, crossover trial.
    Garg A; Grundy SM
    Ann Intern Med; 1994 Sep; 121(6):416-22. PubMed ID: 8053615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary cardiovascular events and serum lipid levels in elderly Japanese with hypercholesterolemia undergoing 6-year simvastatin treatment: a subanalysis of the Japan lipid intervention trial.
    Horiuchi H; Kita T; Mabuchi H; Matsuzaki M; Matsuzawa Y; Nakaya N; Oikawa S; Saito Y; Sasaki J; Shimamoto K; Itakura H;
    J Am Geriatr Soc; 2004 Dec; 52(12):1981-7. PubMed ID: 15571531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.
    Vallejo-Vaz AJ; Robertson M; Catapano AL; Watts GF; Kastelein JJ; Packard CJ; Ford I; Ray KK
    Circulation; 2017 Nov; 136(20):1878-1891. PubMed ID: 28877913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Elevated levels of lipoprotein(a) are present in subjects with early ischemic cardiopathy and with a familial history of ischemic cardiopathy].
    Saitta A; Castaldo M; Sardo A; Cinquegrani M; Bonaiuto M; Zema M; Gravina M; Mangano C
    Minerva Med; 1999; 90(5-6):151-8. PubMed ID: 10780189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipoprotein(a) status in coronary heart disease.
    Khan MA; Baseer A
    J Pak Med Assoc; 2000 Feb; 50(2):47-50. PubMed ID: 10769521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    JAMA; 2002 Dec; 288(23):2998-3007. PubMed ID: 12479764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum carotenoids and coronary heart disease. The Lipid Research Clinics Coronary Primary Prevention Trial and Follow-up Study.
    Morris DL; Kritchevsky SB; Davis CE
    JAMA; 1994 Nov; 272(18):1439-41. PubMed ID: 7933426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Lipid Research Clinics Coronary Primary Prevention Trial. Results of 6 years of post-trial follow-up. The Lipid Research Clinics Investigators.
    Arch Intern Med; 1992 Jul; 152(7):1399-410. PubMed ID: 1627020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
    Pflugfelder PW; Huff M; Oskalns R; Rudas L; Kostuk WJ
    J Heart Lung Transplant; 1995; 14(4):613-22. PubMed ID: 7578166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary and other correlates of changes in total and low density lipoprotein cholesterol in hypercholesterolemic men: the lipid research clinics coronary primary prevention trial.
    Glueck CJ; Gordon DJ; Nelson JJ; Davis CE; Tyroler HA
    Am J Clin Nutr; 1986 Oct; 44(4):489-500. PubMed ID: 3532756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemia.
    Denke MA; Grundy SM
    Arch Intern Med; 1995 Feb; 155(4):393-9. PubMed ID: 7848022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.